Clinical Trial Update: Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial update on tildrakizumab for scalp psoriasis reports efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scalp Psoriasis

Drugs mentioned

• Tildrakizumab (tildrakizumab)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Scalp Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2023-05-31